Biocryst Pharmaceuticals Inc

Mid-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$9.31

+0.17 (+1.86%)

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 15 94%

Hold 1 6%

Sell 0 0%

Price Target

Analyst Price Target +610.2% upside

Low Target $46.17

Average Target $66.12

High Target $78.89

Current Price $9.31

Current
$9.31

Target
$66.12

$46.17 $66.12 avg $78.89

Scenario Analysis

Bear Case

$46.17

395.9%

Low target

Base Case

$66.12

+610.2%

Avg target

Bull Case

$78.89

+747.4%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$10.32

-9.8% from high

52-Week Low

$6.00

+55.2% from low

Target vs 52W High

$66.12

+540.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+9.7%
AMGN Amgen Inc	Hold	44	50%	$190.87	-45.7%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+189.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-7.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-65.2%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-32.8%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-45.0%